MCU and breast carcinoma: Interestingly, two independent studies, in MDA-MB-231 [67] and Hs578t [70] breast cancer cell lines have associated MCU loss to a SOCE defect where MCU silencing considerably reduced cytosolic Ca2+ entry after ER-store depletion upon thapsigargin treatment.